Contact
searchSearch
HMP Global
Sponsored Video

GORE® VIABAHN® FORTEGRA Venous Stent

10/01/2026

Purpose-built for the treatment of inferior vena cava (IVC) obstruction—with or without combined iliofemoral obstruction—the FORTEGRA Venous Stent is the first deep venous stent indicated specifically for this anatomy. Learn more at https://www.goremedical.com/products/fortegra

Related Content

Fadi Saab MD
AMP 2026
Lessons Learned Throughout the Deep Venous Arterialization Evolution: Yesterday and Today
09/29/2026
Fadi Saab, MD, FACC, FSCAI
In this video, interventional cardiologist Fadi Saab, MD discusses one of the presentations he gave at AMP 2026.
In this video, interventional cardiologist Fadi Saab, MD discusses one of the presentations he gave at AMP 2026.
In this video, interventional...
09/29/2026
Vascular Disease Management
Jill Sommerset RVT
AMP 2026
Pre-op Mapping for Deep Vein Arterialization
09/28/2026
Jill Sommerset, RVT
Jill Sommerset, RVT, FSVU, discusses her AMP 2026 presentation on pre-op mapping for DVA.
Jill Sommerset, RVT, FSVU, discusses her AMP 2026 presentation on pre-op mapping for DVA.
Jill Sommerset, RVT, FSVU,...
09/28/2026
Vascular Disease Management
Dr Yana Etkin
AMP 2026
Failing Deep Vein Arterialization: Early Detection and Timely Reintervention Strategies
09/22/2026
Yana Etkin, MD, FSVS, FACS
Vascular surgeon Yana Etkin, MD, discusses her AMP 2026 presentation on failing deep vein arterialization. 
Vascular surgeon Yana Etkin, MD, discusses her AMP 2026 presentation on failing deep vein arterialization. 
Vascular surgeon Yana Etkin, MD,...
09/22/2026
Vascular Disease Management
Dr Mike Watts
ISET 2026
How I Do It: Distal Deep Venous Arterialization in the OBL
02/11/2026
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from...
02/11/2026
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Pulmonary Embolism
AngioDynamics and The PERT Consortium® Name Jacobi Hospital as ALPHA-PE Research Fund Award Recipient to Advance Real-World Pulmonary Embolism Evidence
10/05/2026
LATHAM, N.Y.--(BUSINESS WIRE)--Oct. 2, 2026-- AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient...
LATHAM, N.Y.--(BUSINESS WIRE)--Oct. 2, 2026-- AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient...
LATHAM, N.Y.--(BUSINESS...
10/05/2026
Vascular Disease Management
Pulmonary Embolism
Thrombolex Announces Interim RAPID-PE Results Showing Favorable Safety and Reproducible Multicenter Results in Acute Pulmonary Embolism
10/05/2026
NEW BRITAIN, Pa. — THROMBOLEX, Inc., a leader in the development of innovative treatments for pulmonary embolism (PE), announced the interim analysis of the first 150 patients in RAPID-PE, a prospective, multicenter, single-arm study of...
NEW BRITAIN, Pa. — THROMBOLEX, Inc., a leader in the development of innovative treatments for pulmonary embolism (PE), announced the interim analysis of the first 150 patients in RAPID-PE, a prospective, multicenter, single-arm study of...
NEW BRITAIN, Pa. — THROMBOLEX,...
10/05/2026
Cath Lab Digest
rebranding announcement
Endologix Rebrands as Rhevera Medical
10/05/2026
The company’s technologies include the ALTO® Abdominal Stent Graft System, the AFX®2 Endovascular AAA System, the DETOUR® System for percutaneous bypass in PAD, and the Pounce™ Thrombectomy System.
The company’s technologies include the ALTO® Abdominal Stent Graft System, the AFX®2 Endovascular AAA System, the DETOUR® System for percutaneous bypass in PAD, and the Pounce™ Thrombectomy System.
The company’s technologies...
10/05/2026
Cath Lab Digest
Renal Denervation
Recor Medical Announces AMA CPT Editorial Panel Approval of Two New Category I CPT Codes for Renal Denervation
10/01/2026
The new codes, 37X47 and 37X48, describe percutaneous transcatheter renal sympathetic denervation procedures and are expected to become effective January 1, 2028.
The new codes, 37X47 and 37X48, describe percutaneous transcatheter renal sympathetic denervation procedures and are expected to become effective January 1, 2028.
The new codes, 37X47 and 37X48,...
10/01/2026
Cath Lab Digest
Pulmonary embolism
Inquis Medical Launches First Thrombectomy Catheter with Full 360° Directional Aspiration for Pulmonary Embolism
10/01/2026
MENLO PARK, Calif.--(BUSINESS WIRE)--Inquis Medical, a medical device company pioneering advanced treatments for venous thromboembolic disease, today announced the U.S. commercial launch of the latest AVENTUS™ Catheter, designed to provide...
MENLO PARK, Calif.--(BUSINESS WIRE)--Inquis Medical, a medical device company pioneering advanced treatments for venous thromboembolic disease, today announced the U.S. commercial launch of the latest AVENTUS™ Catheter, designed to provide...
MENLO PARK, Calif.--(BUSINESS...
10/01/2026
Vascular Disease Management
Flow Visualization
The University of Turin Adopts Openwater’s Open-Motion Device to Study Muscle Blood Flow and Vascular Responses
09/29/2026
Open-Motion uses near-infrared light to measure changes in blood flow and blood volume beneath tissue surfaces in real time without invasive procedures.
Open-Motion uses near-infrared light to measure changes in blood flow and blood volume beneath tissue surfaces in real time without invasive procedures.
Open-Motion uses near-infrared...
09/29/2026
Cath Lab Digest
Intravascular Lithotripsy
FastWave Medical Reports 96.4% Procedural Success in First-in-Human Study of Sola Coronary Laser IVL System
09/29/2026
A 30-patient feasibility study demonstrated calcium fracture in every treated lesion and 49% acute lumen gain prior to stenting.
A 30-patient feasibility study demonstrated calcium fracture in every treated lesion and 49% acute lumen gain prior to stenting.
A 30-patient feasibility study...
09/29/2026
Cath Lab Digest
Pulmonary Arterial Hypertension (PAH)
FDA Updates Winrevair Label With HYPERION Data in Newly Diagnosed PAH
09/23/2026
WINREVAIR, an activin signaling inhibitor, is FDA-approved for the treatment of adults with pulmonary arterial hypertension (PAH, WHO Group 1 pulmonary hypertension) to improve exercise capacity and WHO functional class (FC), and reduce the...
WINREVAIR, an activin signaling inhibitor, is FDA-approved for the treatment of adults with pulmonary arterial hypertension (PAH, WHO Group 1 pulmonary hypertension) to improve exercise capacity and WHO functional class (FC), and reduce the...
WINREVAIR, an activin signaling...
09/23/2026
Cath Lab Digest
Hand Protection
Mölnlycke Launches Biogel Radiation Protection Gloves to Tackle Low Adoption of Hand Protection in Radiation-Guided Surgical Procedures
09/22/2026
Mölnlycke Health Care US, LLC. has launched a new surgical glove range designed to reduce clinician hand exposure to scattered radiation during fluoroscopy-guided, interventional and other image-dependent procedures.
Mölnlycke Health Care US, LLC. has launched a new surgical glove range designed to reduce clinician hand exposure to scattered radiation during fluoroscopy-guided, interventional and other image-dependent procedures.
Mölnlycke Health Care US, LLC....
09/22/2026
Cath Lab Digest
TARE vs TACE
TARE Improves Outcomes vs TACE for Large Unresectable HCC
09/14/2026
Laura Simson, MA
A 2026 retrospective study of patients with solitary unresectable hepatocellular carcinoma found that transarterial radioembolization was associated with longer adjusted overall survival and local progression-free survival than transarterial...
A 2026 retrospective study of patients with solitary unresectable hepatocellular carcinoma found that transarterial radioembolization was associated with longer adjusted overall survival and local progression-free survival than transarterial...
A 2026 retrospective study of...
09/14/2026
Vascular Disease Management

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use